News Focus
News Focus
icon url

Mikesc

11/30/17 6:52 PM

#132461 RE: falconer66a #132459

I do like your explanation better.
icon url

polarbear77

11/30/17 6:57 PM

#132463 RE: falconer66a #132459

It would seem the FDA Commissioner might concur with your rationale, Falconer.

[excerpted Dr Gottlieb’s statements in Sept 2017:
https://www.fda.gov/NewsEvents/Speeches/ucm575400.htm

“Our goal is to see how we can accelerate methods that improve our ability to use advanced tools to meet FDA’s gold standard for regulation.

These methods are being applied to both common and rare diseases. FDA is also collaborating with scientists to use similar computational tools to develop natural history models, based on placebo arms in Parkinson’s disease, Huntington’s disease, Alzheimer’s disease, and muscular dystrophy. If we’re able to make better use of rigorous, reliable natural history models, especially for rare diseases, it can help make clinical trial recruitment more efficient.”]
icon url

LakeshoreLeo1953

11/30/17 8:38 PM

#132467 RE: falconer66a #132459

Just consider the time spent convincing a biased public about the efficacy of Cannabis.

There will be skepticism no matter the trial design.
Some will be legitimate scientific questioning.
Some will be agenda driven drivel.

We will see, but not likely in 120 let alone 30 days.
icon url

baltimorebullet

12/01/17 10:31 AM

#132534 RE: falconer66a #132459

Exactly what do you think a placebo effect is?